Cara Therapeutics Inc. (CARA) NASDAQ
$0.67 (0.04) (-5.02%)
Market Cap: $38.66M
As of 04/24/24 04:00 PM EDT. Market closed.
Cara Therapeutics Inc. (CARA)
NASDAQ
$0.67
(0.04) (-5.02%)
Market Cap: $38.66M
As of 04/24/24 04:00 PM EDT. Market closed.
Add to Portfolio
cara therapeutics is an emerging biotechnology company focused on developing novel therapeutics to treat pain, inflammation and pruritus. cara possesses both near-term clinical development opportunities combined with proprietary approaches to developing first-in-class novel therapeutics. cara's most advanced patented compound, cr845, is currently undergoing clinical testing for acute pain and ... read more
COMPANY PROFILE
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
CEO
Derek Chalmers
Full Time Employees
97
CEO Compensation (Base)
$542,100
CEO Compensation (Total)
$2.79M
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
CEO
Derek Chalmers
Full Time Employees
97
CEO Compensation (Base)
$542,100
CEO Compensation (Total)
$2.79M
Address
4 Stamford Plz, Connecticut, Stamford, 06902-3834.
PRICE CHART FOR CARA THERAPEUTICS INC
From:
To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$0.70
Previous Close
$0.71
Days Range
$0.66 - $0.72
52 week range
$0.50 - $4.67
Volume
217,430
Avg. Volume (30 days)
398,109
Market Cap
$38.66M
Dividend Yield
-
P/E
(0.33)
Shares Outstanding
54,667,079
Open
$0.70
Previous Close
$0.71
Days Range
$0.66 - $0.72
52 week range
$0.50 - $4.67
Volume
217,430
Avg. Volume (30 days)
398,109
Market Cap
$38.66M
Dividend Yield
-
P/E
(0.33)
Shares Outstanding
54,667,079
FINANCIAL STATEMENTS FOR CARA THERAPEUTICS INC
LOADING...
Open in: 
Open in:
INSIDER TRANSACTIONS FOR CARA THERAPEUTICS INC
| Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
| Goncalves Joana | CHIEF MEDICAL OFFICER | Apr 05, 2024 | Sale | $0.83 | 2,753 | 2,285 | 53,365 | Apr 09, 2024, 04:22 PM |
| Terrillion Scott | SEC'Y; CHIEF COMPLIANCE & G.C. | Apr 05, 2024 | Sale | $0.83 | 2,753 | 2,285 | 88,247 | Apr 09, 2024, 04:21 PM |
| Terrillion Scott | SEC'Y; CHIEF COMPLIANCE & G.C. | Feb 29, 2024 | Sale | $0.89 | 3,293 | 2,931 | 91,000 | Mar 04, 2024, 04:24 PM |
| Posner Christopher | PRESIDENT AND CEO | Feb 29, 2024 | Sale | $0.89 | 5,834 | 5,192 | 180,521 | Mar 04, 2024, 04:19 PM |
| Goncalves Joana | CHIEF MEDICAL OFFICER | Feb 29, 2024 | Sale | $0.89 | 3,293 | 2,931 | 56,118 | Mar 04, 2024, 04:13 PM |
| Terrillion Scott | SEC'Y; CHIEF COMPLIANCE & G.C. | Feb 08, 2023 | Sale | $0.53 | 7,770 | 4,118 | 94,293 | Feb 12, 2024, 05:16 PM |
| Maynard Ryan D | CHIEF FINANCIAL OFFICER | Feb 08, 2023 | Sale | $0.53 | 5,488 | 2,909 | 8,012 | Feb 12, 2024, 05:15 PM |
| Goncalves Joana | CHIEF MEDICAL OFFICER | Feb 08, 2023 | Sale | $0.53 | 7,770 | 4,118 | 59,411 | Feb 12, 2024, 05:13 PM |
| Posner Christopher | PRESIDENT AND CEO | Feb 08, 2024 | Sale | $0.53 | 35,575 | 18,855 | 186,355 | Feb 12, 2024, 05:10 PM |
| Posner Christopher | PRESIDENT AND CEO | Feb 01, 2024 | Sale | $0.55 | 4,981 | 2,740 | 221,930 | Feb 05, 2024, 04:26 PM |
| Posner Christopher | President and CEO | Nov 02, 2023 | Sale | $1.22 | 3,796 | 4,631 | 164,411 | Nov 03, 2023, 04:37 PM |
| Posner Christopher | President and CEO | Aug 03, 2023 | Sale | $3.07 | 4,307 | 13,222 | 168,207 | Aug 04, 2023, 05:21 PM |
| Terrillion Scott | Sec'y; Chief Compliance & G.C. | Jun 23, 2023 | Sale | $3.51 | 2,483 | 8,715 | 88,563 | Jun 27, 2023, 04:09 PM |
| Menzaghi Frederique Ph.D. | Chief Scientific Off,SVP-R&D | Jun 23, 2023 | Sale | $3.51 | 2,993 | 10,505 | 153,747 | Jun 27, 2023, 04:08 PM |
| Goncalves Joana | Chief Medical Officer | Jun 23, 2023 | Sale | $3.51 | 2,723 | 9,558 | 53,681 | Jun 27, 2023, 04:07 PM |
| Posner Christopher | President and CEO | May 05, 2023 | Sale | $4.40 | 3,869 | 17,024 | 172,514 | May 09, 2023, 04:22 PM |
| Terrillion Scott | Sec'y; Chief Compliance & G.C. | Apr 04, 2023 | Sale | $4.91 | 2,481 | 12,182 | 91,046 | Apr 06, 2023, 05:14 PM |
| Goncalves Joana | Chief Medical Officer | Apr 04, 2023 | Sale | $4.91 | 2,481 | 12,182 | 56,404 | Apr 06, 2023, 05:13 PM |
| Menzaghi Frederique Ph.D. | Chief Scientific Off,SVP-R&D | Apr 04, 2023 | Sale | $4.91 | 2,733 | 13,419 | 156,740 | Apr 06, 2023, 05:12 PM |
| Posner Christopher | President and CEO | Mar 03, 2023 | Sale | $9.71 | 5,987 | 58,134 | 176,383 | Mar 07, 2023, 04:47 PM |
| Menzaghi Frederique Ph.D. | Chief Scientific Off,SVP-R&D | Mar 03, 2023 | Sale | $9.71 | 6,802 | 66,047 | 159,473 | Mar 07, 2023, 04:46 PM |
| Terrillion Scott | Sec'y; Chief Compliance & G.C. | Mar 03, 2023 | Sale | $9.71 | 6,256 | 60,746 | 93,527 | Mar 07, 2023, 04:44 PM |
| Goncalves Joana | Chief Medical Officer | Mar 03, 2023 | Sale | $9.71 | 6,221 | 60,406 | 58,885 | Mar 07, 2023, 04:43 PM |
| Goncalves Joana | Chief Medical Officer | Feb 16, 2023 | Sale | $10.20 | 2,265 | 23,103 | 65,106 | Feb 17, 2023, 04:27 PM |
| Posner Christopher | President and CEO | Feb 02, 2023 | Sale | $11.80 | 4,191 | 49,454 | 182,370 | Feb 03, 2023, 06:38 PM |
| Goncalves Joana | Chief Medical Officer | Jan 17, 2023 | Sale | $10.81 | 2,265 | 24,485 | 67,371 | Jan 19, 2023, 04:18 PM |
| Goncalves Joana | Chief Medical Officer | Dec 29, 2022 | Sale | $10.18 | 2,265 | 23,058 | 69,636 | Jan 03, 2023, 04:32 PM |
| Menzaghi Frederique Ph.D. | Chief Scientific Off,SVP-R&D | Dec 21, 2022 | Sale | $11.27 | 3,506 | 39,513 | 166,275 | Dec 23, 2022, 04:54 PM |
| Goncalves Joana | Chief Medical Officer | Dec 21, 2022 | Sale | $11.27 | 2,992 | 33,720 | 71,901 | Dec 23, 2022, 04:53 PM |
| Terrillion Scott | Sec'y; Chief Compliance & G.C. | Dec 21, 2022 | Sale | $11.27 | 2,561 | 28,862 | 99,783 | Dec 23, 2022, 04:52 PM |
| Posner Christopher | President and CEO | Nov 16, 2022 | Sale | $11.13 | 14,470 | 161,051 | 186,561 | Nov 18, 2022, 05:23 PM |
| VOGELBAUM MARTIN | Director | Sep 14, 2022 | Sale | $10.28 | 10,800 | 111,024 | 44,988 | Sep 16, 2022, 04:21 PM |
| Ives Jeffrey L. | Director | Jul 15, 2022 | Sale | $9.05 | 3,600 | 32,580 | 15,476 | Jul 19, 2022, 05:16 PM |
| BAINS HARRISON M JR | Director | Jul 15, 2022 | Sale | $9.05 | 7,200 | 65,160 | 25,076 | Jul 19, 2022, 05:13 PM |
| Terrillion Scott | Sec'y; Chief Compliance & G.C. | Apr 01, 2022 | Sale | $11.91 | 1,642 | 19,556 | 102,344 | Apr 05, 2022, 05:51 PM |
| Goncalves Joana | Chief Medical Officer | Apr 01, 2022 | Sale | $11.91 | 1,642 | 19,556 | 74,893 | Apr 05, 2022, 05:50 PM |
| Menzaghi Frederique Ph.D. | Chief Scientific Off,SVP-R&D | Apr 01, 2022 | Sale | $11.91 | 1,784 | 21,247 | 169,781 | Apr 05, 2022, 05:49 PM |
| Posner Christopher | President and CEO | Apr 04, 2022 | Sale | $12.67 | 2,006 | 25,416 | 201,031 | Apr 05, 2022, 05:48 PM |
| Reilly Thomas Charles | Chief Financial Officer | Mar 03, 2022 | Sale | $11.38 | 2,044 | 23,261 | 37,811 | Mar 04, 2022, 05:54 PM |
| Terrillion Scott | Sec'y; Chief Compliance & G.C. | Mar 03, 2022 | Sale | $11.38 | 1,787 | 20,336 | 103,986 | Mar 04, 2022, 05:51 PM |
| Terrillion Scott | Sec'y; Chief Compliance & G.C. | Feb 25, 2022 | Sale | $10.29 | 1,972 | 20,292 | 100,440 | Mar 01, 2022, 04:19 PM |
| Ives Jeffrey L. | Director | Nov 12, 2021 | Sale | $16.04 | 8,180 | 131,207 | 7,200 | Nov 16, 2021, 06:15 PM |
| Goncalves Joana | Chief Medical Officer | Nov 01, 2021 | Sale | $17.15 | 1,000 | 17,150 | 45,900 | Nov 03, 2021, 04:55 PM |
| Goncalves Joana | Chief Medical Officer | Oct 27, 2021 | Sale | $15.00 | 1,000 | 15,000 | 46,900 | Oct 28, 2021, 06:34 PM |
| CHALMERS DEREK T | President & CEO | Sep 07, 2021 | Sale | $15.47 | 20,000 | 309,400 | 991,405 | Sep 09, 2021, 04:48 PM |
| Terrillion Scott | Sec'y; Chief Compliance & G.C. | Aug 30, 2021 | Sale | $14.20 | 1,759 | 24,978 | 70,917 | Sep 01, 2021, 06:09 PM |
| Reilly Thomas Charles | Chief Financial Officer | Aug 30, 2021 | Sale | $14.20 | 1,982 | 28,144 | 3,352 | Sep 01, 2021, 06:08 PM |
| Menzaghi Frederique Ph.D. | Chief Scientific Off,SVP-R&D | Aug 30, 2021 | Sale | $14.20 | 3,847 | 54,627 | 141,072 | Sep 01, 2021, 06:07 PM |
| Goncalves Joana | Chief Medical Officer | Aug 30, 2021 | Sale | $14.20 | 2,110 | 29,962 | 47,900 | Sep 01, 2021, 06:06 PM |
| CHALMERS DEREK T | President & CEO | Aug 30, 2021 | Sale | $14.20 | 8,440 | 119,848 | 1,011,405 | Sep 01, 2021, 06:04 PM |
| VOGELBAUM MARTIN | Director | Jun 07, 2021 | Sale | $13.05 | 8,640 | 112,752 | 20,160 | Jun 07, 2021, 07:35 PM |
| Posner Christopher | Director | Jun 07, 2021 | Sale | $13.04 | 2,304 | 30,044 | 16,096 | Jun 07, 2021, 07:33 PM |
| Ives Jeffrey L. | Director | Jun 07, 2021 | Sale | $13.05 | 2,520 | 32,886 | 15,380 | Jun 07, 2021, 07:25 PM |
| Goncalves Joana | Chief Medical Officer | Apr 21, 2021 | Sale | $27.63 | 3,000 | 82,890 | 43,610 | Apr 23, 2021, 05:05 PM |
| Goncalves Joana | Chief Medical Officer | Mar 22, 2021 | Sale | $19.65 | 3,000 | 58,950 | 30,610 | Mar 24, 2021, 05:55 PM |
| Menzaghi Frederique Ph.D. | Chief Scientific Off,SVP-R&D | Mar 05, 2021 | Sale | $17.98 | 3,358 | 60,377 | 119,319 | Mar 08, 2021, 05:48 PM |
| Terrillion Scott | Sec'y; Chief Compliance & G.C. | Mar 05, 2021 | Sale | $17.98 | 3,090 | 55,558 | 51,342 | Mar 08, 2021, 05:47 PM |
| Goncalves Joana | Chief Medical Officer | Mar 05, 2021 | Sale | $17.98 | 3,093 | 55,612 | 33,610 | Mar 08, 2021, 05:45 PM |
| CHALMERS DEREK T | President & CEO | Mar 05, 2021 | Sale | $17.98 | 3,103 | 55,792 | 950,511 | Mar 08, 2021, 05:44 PM |
| Terrillion Scott | Sec'y; Chief Compliance & G.C. | Feb 25, 2021 | Sale | $19.33 | 4,004 | 77,397 | 44,432 | Feb 25, 2021, 09:06 PM |
| Menzaghi Frederique Ph.D. | Chief Scientific Off,SVP-R&D | Feb 25, 2021 | Sale | $19.33 | 5,003 | 96,708 | 112,677 | Feb 25, 2021, 09:05 PM |
| Goncalves Joana | Chief Medical Officer | Feb 25, 2021 | Sale | $19.33 | 3,372 | 65,181 | 26,703 | Feb 25, 2021, 09:04 PM |
| CHALMERS DEREK T | President & CEO | Feb 25, 2021 | Sale | $19.33 | 11,729 | 226,722 | 943,614 | Feb 25, 2021, 09:02 PM |
| Goncalves Joana | Chief Medical Officer | Feb 22, 2021 | Sale | $19.73 | 2,000 | 39,460 | 26,075 | Feb 24, 2021, 05:02 PM |
| Goncalves Joana | Chief Medical Officer | Jan 21, 2021 | Sale | $20.12 | 2,000 | 40,240 | 28,075 | Jan 25, 2021, 05:32 PM |
| Terrillion Scott | Sec'y; Chief Compliance & G.C. | Dec 30, 2020 | Sale | $15.30 | 1,946 | 29,774 | 42,436 | Dec 30, 2020, 06:16 PM |
| Menzaghi Frederique Ph.D. | Chief Scientific Off,SVP-R&D | Dec 30, 2020 | Sale | $15.30 | 2,812 | 43,024 | 109,680 | Dec 30, 2020, 06:15 PM |
| Goncalves Joana | Chief Medical Officer | Dec 30, 2020 | Sale | $15.30 | 1,298 | 19,859 | 30,075 | Dec 30, 2020, 06:14 PM |
| CHALMERS DEREK T | President & CEO | Dec 30, 2020 | Sale | $15.30 | 6,078 | 92,993 | 936,593 | Dec 30, 2020, 06:12 PM |
| CHALMERS DEREK T | President & CEO | Dec 28, 2020 | Sale | $16.00 | 5,000 | 80,000 | 942,671 | Dec 29, 2020, 06:41 PM |
| Goncalves Joana | Chief Medical Officer | Dec 21, 2020 | Sale | $15.00 | 2,000 | 30,000 | 27,373 | Dec 23, 2020, 07:11 PM |
| CHALMERS DEREK T | President & CEO | Dec 16, 2020 | Sale | $14.95 | 5,000 | 74,750 | 928,921 | Dec 18, 2020, 04:58 PM |
| CHALMERS DEREK T | President & CEO | Dec 10, 2020 | Sale | $15.29 | 7,500 | 114,675 | 933,921 | Dec 11, 2020, 08:32 PM |
| Goncalves Joana | Chief Medical Officer | Nov 23, 2020 | Sale | $15.31 | 2,000 | 30,620 | 29,373 | Nov 25, 2020, 04:48 PM |
| Ives Jeffrey L. | Director | Nov 19, 2020 | Sale | $15.75 | 2,500 | 39,372 | 10,700 | Nov 24, 2020, 05:46 PM |
| Posner Christopher | Director | Nov 19, 2020 | Sale | $15.82 | 2,000 | 31,638 | 11,200 | Nov 23, 2020, 08:28 PM |
| Ives Jeffrey L. | Director | Nov 19, 2020 | Option Exercise | $15.75 | 2,500 | 39,372 | 10,700 | Nov 23, 2020, 08:26 PM |
| VOGELBAUM MARTIN | Director | Nov 17, 2020 | Sale | $16.09 | 6,000 | 96,540 | 14,400 | Nov 19, 2020, 05:30 PM |
| CHALMERS DEREK T | President & CEO | Nov 17, 2020 | Sale | $16.00 | 11,799 | 188,784 | 941,421 | Nov 19, 2020, 05:29 PM |
| Goncalves Joana | Chief Medical Officer | Nov 10, 2020 | Sale | $15.00 | 2,000 | 30,000 | 31,373 | Nov 13, 2020, 05:39 PM |
| Goncalves Joana | Chief Medical Officer | Oct 20, 2020 | Sale | $15.00 | 2,000 | 30,000 | 33,373 | Oct 22, 2020, 06:00 PM |
| CHALMERS DEREK T | President & CEO | Sep 03, 2020 | Sale | $16.00 | 3,201 | 51,216 | 953,220 | Sep 08, 2020, 05:22 PM |
| CHALMERS DEREK T | President & CEO | Aug 03, 2020 | Sale | $16.42 | 5,000 | 82,100 | 956,421 | Aug 05, 2020, 06:20 PM |
| CHALMERS DEREK T | President & CEO | Jul 01, 2020 | Sale | $17.11 | 5,000 | 85,550 | 961,421 | Jul 02, 2020, 04:40 PM |
| Goncalves Joana | Chief Medical Officer | Jun 12, 2020 | Sale | $15.20 | 10,627 | 161,530 | 35,373 | Jun 12, 2020, 06:00 PM |
| CHALMERS DEREK T | President & CEO | Jun 03, 2020 | Sale | $16.01 | 4,300 | 68,843 | 966,421 | Jun 03, 2020, 07:53 PM |
| CHALMERS DEREK T | President & CEO | Jun 01, 2020 | Sale | $16.00 | 700 | 11,200 | 970,721 | Jun 03, 2020, 07:53 PM |
| Ives Jeffrey L. | Director | Jun 01, 2020 | Option Exercise | $9.94 | 1,000 | 9,940 | 7,000 | Jun 03, 2020, 07:51 PM |
| Ives Jeffrey L. | Director | Jun 01, 2020 | Sale | $16.00 | 1,000 | 16,000 | 6,000 | Jun 03, 2020, 07:51 PM |
| CHALMERS DEREK T | President & CEO | May 20, 2020 | Sale | $16.00 | 1,200 | 19,200 | 975,292 | May 22, 2020, 06:26 PM |
| CHALMERS DEREK T | President & CEO | May 22, 2020 | Sale | $16.00 | 371 | 5,936 | 971,421 | May 22, 2020, 06:26 PM |
| CHALMERS DEREK T | President & CEO | May 21, 2020 | Sale | $16.00 | 3,500 | 56,000 | 971,792 | May 22, 2020, 06:26 PM |
| CHALMERS DEREK T | President & CEO | May 12, 2020 | Sale | $16.00 | 4,929 | 78,864 | 976,492 | May 14, 2020, 08:04 PM |
| Ives Jeffrey L. | Director | May 12, 2020 | Option Exercise | $9.94 | 2,500 | 24,850 | 8,500 | May 14, 2020, 08:02 PM |
| Ives Jeffrey L. | Director | May 12, 2020 | Sale | $16.00 | 2,500 | 40,000 | 6,000 | May 14, 2020, 08:02 PM |
| Ives Jeffrey L. | Director | Apr 21, 2020 | Option Exercise | $9.94 | 2,500 | 24,850 | 8,500 | Apr 21, 2020, 07:09 PM |
| Ives Jeffrey L. | Director | Apr 21, 2020 | Sale | $16.00 | 2,500 | 40,000 | 6,000 | Apr 21, 2020, 07:09 PM |
| Terrillion Scott | Sec'y; Chief Compliance & G.C. | Apr 21, 2020 | Sale | $15.56 | 2,721 | 42,339 | 38,382 | Apr 21, 2020, 06:50 PM |
| Menzaghi Frederique Ph.D. | Chief Scientific Off,SVP-R&D | Apr 21, 2020 | Sale | $15.58 | 12,894 | 200,889 | 104,492 | Apr 21, 2020, 06:49 PM |
| CHALMERS DEREK T | President & CEO | Apr 21, 2020 | Sale | $15.56 | 6,348 | 98,775 | 981,421 | Apr 21, 2020, 06:47 PM |
| Ives Jeffrey L. | Director | Mar 04, 2020 | Option Exercise | $9.94 | 2,500 | 24,850 | 8,500 | Mar 06, 2020, 04:39 PM |
| Ives Jeffrey L. | Director | Mar 04, 2020 | Sale | $16.00 | 2,500 | 40,000 | 6,000 | Mar 06, 2020, 04:39 PM |
| Ives Jeffrey L. | Director | Feb 03, 2020 | Option Exercise | $9.94 | 2,500 | 24,850 | 8,500 | Feb 05, 2020, 05:01 PM |
| Ives Jeffrey L. | Director | Feb 03, 2020 | Sale | $16.23 | 2,500 | 40,575 | 6,000 | Feb 05, 2020, 05:01 PM |
| Ives Jeffrey L. | Director | Jan 02, 2020 | Option Exercise | $9.94 | 2,500 | 24,850 | 8,500 | Jan 06, 2020, 06:06 PM |
| Ives Jeffrey L. | Director | Jan 02, 2020 | Sale | $16.13 | 2,500 | 40,325 | 6,000 | Jan 06, 2020, 06:06 PM |
| CHALMERS DEREK T | President & CEO | Jan 02, 2020 | Sale | $16.05 | 10,000 | 160,500 | 917,769 | Jan 06, 2020, 06:05 PM |
| Terrillion Scott | Sec'y; Chief Compliance & G.C. | Dec 04, 2019 | Sale | $17.05 | 3,980 | 67,859 | 16,769 | Dec 04, 2019, 07:52 PM |
| Mohindru Mani | CFO & Chief Strategy Officer | Dec 04, 2019 | Sale | $17.05 | 4,755 | 81,073 | 17,441 | Dec 04, 2019, 07:50 PM |
| Ives Jeffrey L. | Director | Dec 02, 2019 | Option Exercise | $5.32 | 2,500 | 13,300 | 8,500 | Dec 04, 2019, 07:49 PM |
| Ives Jeffrey L. | Director | Dec 02, 2019 | Sale | $25.83 | 2,500 | 64,575 | 6,000 | Dec 04, 2019, 07:49 PM |
| CHALMERS DEREK T | President & CEO | Dec 04, 2019 | Sale | $17.05 | 10,699 | 182,418 | 927,769 | Dec 04, 2019, 07:47 PM |
| CHALMERS DEREK T | President & CEO | Dec 02, 2019 | Sale | $25.79 | 10,000 | 257,900 | 918,468 | Dec 04, 2019, 07:47 PM |
| Ives Jeffrey L. | Director | Nov 01, 2019 | Option Exercise | $5.32 | 2,500 | 13,300 | 8,500 | Nov 05, 2019, 06:21 PM |
| Ives Jeffrey L. | Director | Nov 01, 2019 | Sale | $20.68 | 2,500 | 51,700 | 6,000 | Nov 05, 2019, 06:21 PM |
| CHALMERS DEREK T | President & CEO | Nov 01, 2019 | Sale | $20.79 | 5,000 | 103,950 | 928,468 | Nov 05, 2019, 06:07 PM |
| Menzaghi Frederique Ph.D. | Chief Scientific Off,SVP-R&D | Oct 25, 2019 | Sale | $19.91 | 4,000 | 79,640 | 63,886 | Oct 29, 2019, 08:36 PM |
| Menzaghi Frederique Ph.D. | Chief Scientific Off,SVP-R&D | Oct 18, 2019 | Sale | $19.33 | 4,000 | 77,320 | 67,886 | Oct 22, 2019, 05:01 PM |
| Menzaghi Frederique Ph.D. | Chief Scientific Off,SVP-R&D | Oct 11, 2019 | Sale | $18.70 | 4,000 | 74,800 | 71,886 | Oct 16, 2019, 06:26 PM |
| Menzaghi Frederique Ph.D. | Chief Scientific Off,SVP-R&D | Oct 04, 2019 | Sale | $19.19 | 4,000 | 76,760 | 75,886 | Oct 08, 2019, 04:44 PM |
| Ives Jeffrey L. | Director | Oct 01, 2019 | Option Exercise | $5.32 | 2,500 | 13,300 | 8,500 | Oct 03, 2019, 09:19 PM |
| Ives Jeffrey L. | Director | Oct 01, 2019 | Sale | $18.21 | 2,500 | 45,525 | 6,000 | Oct 03, 2019, 09:19 PM |
| CHALMERS DEREK T | President & CEO | Oct 01, 2019 | Sale | $18.28 | 10,000 | 182,800 | 933,468 | Oct 03, 2019, 09:17 PM |
| Menzaghi Frederique Ph.D. | Chief Scientific Off,SVP-R&D | Sep 03, 2019 | Sale | $22.92 | 20,000 | 458,400 | 79,886 | Sep 05, 2019, 05:38 PM |
| Ives Jeffrey L. | Director | Sep 03, 2019 | Option Exercise | $5.32 | 2,500 | 13,300 | 8,500 | Sep 05, 2019, 05:37 PM |
| Ives Jeffrey L. | Director | Sep 03, 2019 | Sale | $23.31 | 2,500 | 58,275 | 6,000 | Sep 05, 2019, 05:37 PM |
| CHALMERS DEREK T | President & CEO | Sep 03, 2019 | Sale | $23.26 | 5,000 | 116,300 | 943,468 | Sep 05, 2019, 05:36 PM |
| Menzaghi Frederique Ph.D. | Chief Scientific Off,SVP-R&D | Aug 01, 2019 | Sale | $23.24 | 20,000 | 464,800 | 99,886 | Aug 05, 2019, 05:33 PM |
| Ives Jeffrey L. | Director | Aug 01, 2019 | Option Exercise | $5.32 | 2,500 | 13,300 | 8,500 | Aug 05, 2019, 05:32 PM |
| Ives Jeffrey L. | Director | Aug 01, 2019 | Sale | $23.24 | 2,500 | 58,100 | 6,000 | Aug 05, 2019, 05:32 PM |
| CHALMERS DEREK T | President & CEO | Aug 01, 2019 | Sale | $23.27 | 10,000 | 232,700 | 948,468 | Aug 05, 2019, 05:31 PM |
| Menzaghi Frederique Ph.D. | Chief Scientific Off,SVP-R&D | Jul 17, 2019 | Sale | $27.50 | 8,996 | 247,390 | 119,886 | Jul 19, 2019, 05:47 PM |
| Mohindru Mani | CFO & Chief Strategy Officer | Jul 15, 2019 | Option Exercise | $14.06 | 37,431 | 526,280 | 51,294 | Jul 17, 2019, 05:46 PM |
| Mohindru Mani | CFO & Chief Strategy Officer | Jul 15, 2019 | Sale | $25.00 | 37,431 | 935,775 | 13,863 | Jul 17, 2019, 05:46 PM |
| Ives Jeffrey L. | Director | Jul 01, 2019 | Option Exercise | $5.32 | 2,500 | 13,300 | 8,500 | Jul 03, 2019, 04:04 PM |
| Ives Jeffrey L. | Director | Jul 01, 2019 | Sale | $21.75 | 2,500 | 54,375 | 6,000 | Jul 03, 2019, 04:04 PM |
| Menzaghi Frederique Ph.D. | Chief Scientific Off,SVP-R&D | Jul 01, 2019 | Sale | $21.90 | 20,000 | 438,000 | 128,882 | Jul 03, 2019, 03:59 PM |
| Terrillion Scott | Sec'y; Chief Compliance & G.C. | May 29, 2019 | Sale | $21.38 | 2,303 | 49,238 | 12,416 | May 30, 2019, 06:19 PM |
| CHALMERS DEREK T | President & CEO | May 29, 2019 | Sale | $21.42 | 5,528 | 118,410 | 958,468 | May 30, 2019, 06:18 PM |
| Mohindru Mani | CFO & Chief Strategy Officer | May 29, 2019 | Sale | $21.39 | 2,496 | 53,389 | 13,863 | May 30, 2019, 06:17 PM |
| Menzaghi Frederique Ph.D. | Chief Scientific Off,SVP-R&D | May 29, 2019 | Sale | $21.19 | 11,397 | 241,502 | 148,882 | May 30, 2019, 06:16 PM |
| Mohindru Mani | CFO & Chief Strategy Officer | Mar 13, 2019 | Option Exercise | $14.06 | 16,041 | 225,536 | 24,067 | Mar 15, 2019, 04:42 PM |
| Mohindru Mani | CFO & Chief Strategy Officer | Mar 13, 2019 | Sale | $19.12 | 16,041 | 306,704 | 8,026 | Mar 15, 2019, 04:42 PM |
| Menzaghi Frederique Ph.D. | Chief Scientific Off,SVP-R&D | Mar 13, 2019 | Sale | $18.87 | 16,803 | 317,073 | 122,779 | Mar 14, 2019, 05:13 PM |
| Menzaghi Frederique Ph.D. | Chief Scientific Off,SVP-R&D | Mar 12, 2019 | Sale | $17.50 | 3,197 | 55,948 | 139,582 | Mar 14, 2019, 05:13 PM |
| CHALMERS DEREK T | President & CEO | Mar 01, 2019 | Sale | $17.04 | 9,792 | 166,856 | 943,996 | Mar 05, 2019, 04:53 PM |
| Menzaghi Frederique Ph.D. | Sr VP-Research & Development | Feb 28, 2019 | Sale | $17.50 | 1,500 | 26,250 | 142,779 | Mar 04, 2019, 05:49 PM |
| Menzaghi Frederique Ph.D. | Sr VP-Research & Development | Feb 25, 2019 | Sale | $17.50 | 2,200 | 38,500 | 144,279 | Feb 27, 2019, 05:29 PM |
| CHALMERS DEREK T | President & CEO | Feb 01, 2019 | Sale | $14.99 | 20,000 | 299,800 | 953,788 | Feb 05, 2019, 04:27 PM |
| CHALMERS DEREK T | President & CEO | Jan 02, 2019 | Sale | $13.13 | 15,000 | 196,950 | 978,788 | Jan 04, 2019, 04:22 PM |
| CHALMERS DEREK T | President & CEO | Jan 04, 2019 | Sale | $15.04 | 5,000 | 75,200 | 973,788 | Jan 04, 2019, 04:22 PM |
| Menzaghi Frederique Ph.D. | Sr VP-Research & Development | Dec 28, 2018 | Sale | $12.53 | 4,300 | 53,879 | 146,479 | Jan 02, 2019, 05:56 PM |
| Terrillion Scott | Sec'y; Chief Compliance & G.C. | Dec 28, 2018 | Sale | $12.51 | 3,100 | 38,781 | 6,386 | Jan 02, 2019, 05:56 PM |
| CHALMERS DEREK T | President & CEO | Dec 28, 2018 | Sale | $12.53 | 15,825 | 198,287 | 993,788 | Jan 02, 2019, 05:55 PM |
| Mohindru Mani | CFO & Chief Strategy Officer | Dec 28, 2018 | Sale | $12.55 | 4,500 | 56,475 | 8,026 | Jan 02, 2019, 05:54 PM |
| Menzaghi Frederique Ph.D. | Sr VP-Research & Development | Dec 03, 2018 | Sale | $18.36 | 3,000 | 55,080 | 139,000 | Dec 06, 2018, 04:18 PM |
| CHALMERS DEREK T | President & CEO | Dec 03, 2018 | Sale | $18.17 | 20,000 | 363,400 | 971,392 | Dec 06, 2018, 04:16 PM |
| Mohindru Mani | CFO & Chief Strategy Officer | Nov 15, 2018 | Option Exercise | $14.06 | 16,042 | 225,551 | 16,042 | Nov 16, 2018, 04:22 PM |
| Mohindru Mani | CFO & Chief Strategy Officer | Nov 15, 2018 | Sale | $18.50 | 16,042 | 296,777 | 0 | Nov 16, 2018, 04:22 PM |
| Menzaghi Frederique Ph.D. | Sr VP-Research & Development | Nov 01, 2018 | Option Exercise | $2.05 | 40,000 | 82,000 | 145,000 | Nov 05, 2018, 08:25 PM |
| Menzaghi Frederique Ph.D. | Sr VP-Research & Development | Nov 01, 2018 | Sale | $18.77 | 3,000 | 56,310 | 142,000 | Nov 05, 2018, 08:25 PM |
| Menzaghi Frederique Ph.D. | Sr VP-Research & Development | Aug 06, 2018 | Option Exercise | $2.25 | 10,000 | 22,500 | 114,000 | Nov 05, 2018, 08:21 PM |
| CHALMERS DEREK T | President & CEO | Nov 01, 2018 | Sale | $18.78 | 20,000 | 375,600 | 991,392 | Nov 02, 2018, 05:35 PM |
| Stauffer Joseph William | Chief Medical Officer | Oct 17, 2018 | Sale | $20.13 | 11,442 | 230,347 | 2,970 | Oct 19, 2018, 04:34 PM |
| Mohindru Mani | CFO & Chief Strategy Officer | Oct 17, 2018 | Option Exercise | $14.06 | 16,042 | 225,551 | 16,042 | Oct 19, 2018, 04:32 PM |
| Mohindru Mani | CFO & Chief Strategy Officer | Oct 17, 2018 | Sale | $20.19 | 16,042 | 323,888 | 0 | Oct 19, 2018, 04:32 PM |
| Menzaghi Frederique Ph.D. | Sr VP-Research & Development | Oct 01, 2018 | Sale | $23.99 | 3,000 | 71,970 | 95,000 | Oct 03, 2018, 04:09 PM |
| CHALMERS DEREK T | President & CEO | Oct 01, 2018 | Sale | $23.79 | 20,000 | 475,800 | 1,011,392 | Oct 03, 2018, 04:08 PM |
| CHALMERS DEREK T | President & CEO | Sep 04, 2018 | Sale | $19.71 | 20,000 | 394,200 | 1,031,392 | Sep 06, 2018, 05:34 PM |
| Menzaghi Frederique Ph.D. | Sr VP-Research & Development | Sep 04, 2018 | Sale | $19.81 | 3,000 | 59,430 | 98,000 | Sep 06, 2018, 05:33 PM |
| Menzaghi Frederique Ph.D. | Sr VP-Research & Development | Aug 20, 2018 | Sale | $18.89 | 3,000 | 56,670 | 101,000 | Aug 22, 2018, 05:26 PM |
| CHALMERS DEREK T | President & CEO | Jul 10, 2018 | Sale | $20.64 | 20,000 | 412,800 | 1,051,392 | Jul 12, 2018, 04:42 PM |
| Menzaghi Frederique Ph.D. | Sr VP-Research & Development | Jul 02, 2018 | Sale | $19.00 | 3,000 | 57,000 | 104,000 | Jul 05, 2018, 05:00 PM |
| Menzaghi Frederique Ph.D. | Sr VP-Research & Development | Jun 01, 2018 | Sale | $15.49 | 3,000 | 46,470 | 107,000 | Jun 05, 2018, 07:15 PM |
| Menzaghi Frederique Ph.D. | Sr VP-Research & Development | May 23, 2018 | Sale | $15.19 | 9,000 | 136,710 | 110,000 | May 25, 2018, 04:22 PM |
| CHALMERS DEREK T | President & CEO | Feb 16, 2018 | Sale | $15.00 | 5,400 | 81,000 | 1,071,392 | Feb 21, 2018, 05:13 PM |
| Menzaghi Frederique Ph.D. | Sr VP-Research & Development | Feb 15, 2018 | Sale | $15.02 | 3,000 | 45,060 | 119,000 | Feb 20, 2018, 04:43 PM |
| Menzaghi Frederique Ph.D. | Sr VP-Research & Development | Jan 24, 2018 | Sale | $15.00 | 15,000 | 225,000 | 122,000 | Jan 26, 2018, 05:53 PM |
| CHALMERS DEREK T | President & CEO | Jan 25, 2018 | Option Exercise | $6.00 | 3,000 | 18,000 | 1,076,792 | Jan 26, 2018, 05:52 PM |
| CHALMERS DEREK T | President & CEO | Jan 24, 2018 | Sale | $15.00 | 12,500 | 187,500 | 1,073,792 | Jan 26, 2018, 05:52 PM |
| Menzaghi Frederique Ph.D. | Sr VP-Research & Development | Nov 07, 2017 | Option Exercise | $2.48 | 20,000 | 49,600 | 137,000 | Nov 09, 2017, 04:36 PM |
| CHALMERS DEREK T | President & CEO | Nov 03, 2017 | Option Exercise | $2.48 | 20,000 | 49,600 | 1,086,292 | Nov 03, 2017, 05:27 PM |
| CHALMERS DEREK T | President & CEO | Nov 01, 2017 | Sale | $12.66 | 16,000 | 202,560 | 1,066,292 | Nov 03, 2017, 05:27 PM |
| Menzaghi Frederique Ph.D. | VP-Research & Development | Aug 04, 2017 | Sale | $15.00 | 3,000 | 45,000 | 117,000 | Aug 10, 2017, 05:47 PM |
| Schoell Josef | Chief Financial Officer | Jul 26, 2017 | Option Exercise | $2.25 | 4,000 | 9,000 | 50,000 | Jul 28, 2017, 04:53 PM |
| CHALMERS DEREK T | President & CEO | Jul 14, 2017 | Option Exercise | $2.48 | 10,000 | 24,800 | 1,107,292 | Jul 18, 2017, 06:10 PM |
| CHALMERS DEREK T | President & CEO | Jul 14, 2017 | Sale | $15.05 | 25,000 | 376,250 | 1,082,292 | Jul 18, 2017, 06:10 PM |
| Menzaghi Frederique Ph.D. | VP-Research & Development | Jul 14, 2017 | Sale | $15.00 | 3,000 | 45,000 | 120,000 | Jul 18, 2017, 06:09 PM |
| Slagel Dean | Director | Jun 29, 2017 | Sale | $25.87 | 250,000 | 6,468,564 | 1,085,200 | Jul 03, 2017, 05:53 PM |
| RHO Ventures VI LP | 10% Owner | Mar 31, 2017 | Buy | $18.19 | 500,000 | 9,095,700 | 3,568,057 | Apr 03, 2017, 09:19 AM |
| Menzaghi Frederique Ph.D. | VP-Research & Development | Apr 20, 2016 | Sale | $9.00 | 6,000 | 54,000 | 123,000 | Apr 20, 2016, 05:34 PM |
| VOGELBAUM MARTIN | Director | Mar 17, 2016 | Buy | $4.93 | 247,727 | 1,221,368 | 3,068,057 | Mar 18, 2016, 07:43 PM |
| VOGELBAUM MARTIN | Director | Mar 16, 2016 | Buy | $4.78 | 152,273 | 727,834 | 2,820,330 | Mar 18, 2016, 07:43 PM |
| RHO Ventures VI LP | 10% Owner | Mar 17, 2016 | Buy | $4.93 | 247,727 | 1,221,368 | 3,068,057 | Mar 18, 2016, 07:22 PM |
| RHO Ventures VI LP | 10% Owner | Mar 16, 2016 | Buy | $4.78 | 152,273 | 727,834 | 2,820,330 | Mar 18, 2016, 07:22 PM |
| Schoell Josef | Chief Financial Officer | Mar 16, 2016 | Option Exercise | $0.82 | 18,000 | 14,740 | 46,000 | Mar 17, 2016, 08:22 PM |
| CHALMERS DEREK T | President & CEO | Mar 15, 2016 | Option Exercise | $2.48 | 10,000 | 24,800 | 1,097,292 | Mar 17, 2016, 05:59 PM |
| Menzaghi Frederique Ph.D. | VP-Research & Development | Feb 03, 2016 | Sale | $9.00 | 1,000 | 9,000 | 129,000 | Feb 03, 2016, 04:41 PM |
| Menzaghi Frederique Ph.D. | VP-Research & Development | Feb 01, 2016 | Sale | $9.05 | 5,000 | 45,250 | 130,000 | Feb 03, 2016, 04:41 PM |
| Lewis Michael E | Chief Scientific Advisor | Jan 26, 2016 | Sale | $10.93 | 7,262 | 79,374 | 314,988 | Jan 27, 2016, 05:10 PM |
| Slagel Dean | Director | Jan 05, 2016 | Sale | $17.01 | 31,224 | 531,120 | 1,314,338 | Jan 12, 2016, 07:00 PM |
| Slagel Dean | Director | Dec 31, 2015 | Sale | $17.00 | 12,776 | 217,192 | 1,345,562 | Jan 12, 2016, 07:00 PM |
| CHALMERS DEREK T | President & CEO | Jan 06, 2016 | Sale | $17.22 | 12,500 | 215,250 | 1,087,292 | Jan 07, 2016, 08:31 PM |
| Menzaghi Frederique Ph.D. | VP-Research & Development | Jan 04, 2016 | Sale | $16.80 | 6,000 | 100,800 | 135,000 | Jan 05, 2016, 04:56 PM |
| Slagel Dean | Director | Jan 05, 2016 | Sale | $17.01 | 31,224 | 531,120 | 1,314,338 | Jan 05, 2016, 04:54 PM |
| Slagel Dean | Director | Dec 31, 2015 | Sale | $17.00 | 12,776 | 217,192 | 1,345,562 | Jan 05, 2016, 04:54 PM |
| Menzaghi Frederique Ph.D. | VP-Research & Development | Dec 01, 2015 | Sale | $16.21 | 6,000 | 97,260 | 141,000 | Dec 03, 2015, 05:17 PM |
| Menzaghi Frederique Ph.D. | VP-Research & Development | Nov 02, 2015 | Sale | $14.26 | 6,000 | 85,560 | 147,000 | Nov 03, 2015, 06:08 PM |
| Menzaghi Frederique Ph.D. | VP-Research & Development | Oct 01, 2015 | Sale | $13.95 | 6,000 | 83,715 | 154,500 | Oct 05, 2015, 04:57 PM |
| Menzaghi Frederique Ph.D. | VP-Research & Development | Sep 01, 2015 | Sale | $18.63 | 7,000 | 130,410 | 159,000 | Sep 03, 2015, 05:52 PM |
| Schoell Josef | Chief Financial Officer | Aug 18, 2015 | Buy | $22.10 | 3,000 | 66,300 | 28,000 | Aug 19, 2015, 06:03 PM |
| Stauffer Joseph William | Chief Medical Officer | Aug 04, 2015 | Buy | $18.60 | 2,000 | 37,200 | 13,442 | Aug 06, 2015, 04:46 PM |
| Menzaghi Frederique Ph.D. | VP-Research & Development | Aug 03, 2015 | Sale | $21.41 | 7,000 | 149,870 | 166,000 | Aug 05, 2015, 05:16 PM |
| Menzaghi Frederique Ph.D. | VP-Research & Development | Jul 01, 2015 | Sale | $12.22 | 7,000 | 85,540 | 173,000 | Jul 06, 2015, 05:06 PM |
| Lewis Michael E | Chief Scientific Advisor | Jul 01, 2015 | Sale | $11.66 | 7,262 | 84,675 | 322,250 | Jul 06, 2015, 05:03 PM |
| Lewis Michael E | Chief Scientific Advisor | Jun 01, 2015 | Sale | $9.50 | 7,262 | 68,989 | 329,512 | Jun 02, 2015, 06:11 PM |
| Slagel Dean | Director | May 15, 2015 | Sale | $10.00 | 73,600 | 736,000 | 1,473,549 | May 19, 2015, 05:11 PM |
| Slagel Dean | Director | May 19, 2015 | Sale | $10.00 | 32,266 | 322,660 | 1,358,338 | May 19, 2015, 05:11 PM |
| Slagel Dean | Director | May 18, 2015 | Sale | $10.04 | 82,945 | 832,768 | 1,390,604 | May 19, 2015, 05:11 PM |
| Lewis Michael E | Chief Scientific Advisor | May 01, 2015 | Sale | $10.64 | 7,262 | 77,268 | 336,774 | May 05, 2015, 04:49 PM |
| Lewis Michael E | Chief Scientific Advisor | Apr 01, 2015 | Sale | $9.90 | 7,262 | 71,894 | 344,036 | Apr 02, 2015, 05:34 PM |
| Menzaghi Frederique Ph.D. | VP-Research & Development | Mar 09, 2015 | Option Exercise | $0.25 | 20,000 | 5,000 | 180,000 | Mar 11, 2015, 04:54 PM |
| Lewis Michael E | Chief Scientific Advisor | Mar 02, 2015 | Sale | $10.11 | 7,262 | 73,419 | 351,298 | Mar 03, 2015, 06:42 PM |
| Schoell Josef | Chief Financial Officer | Feb 17, 2015 | Sale | $10.96 | 15,000 | 164,400 | 25,000 | Feb 19, 2015, 06:00 PM |
| Lewis Michael E | Chief Scientific Advisor | Feb 02, 2015 | Sale | $10.60 | 7,262 | 76,977 | 358,560 | Feb 03, 2015, 05:35 PM |
| Stauffer Joseph William | Chief Medical Officer | Dec 01, 2014 | Option Exercise | $8.74 | 11,442 | 100,003 | 11,442 | Dec 03, 2014, 07:23 PM |
| Schoell Josef | Chief Financial Officer | Aug 14, 2014 | Option Exercise | $0.25 | 40,000 | 10,000 | 40,000 | Aug 14, 2014, 06:24 PM |
| VOGELBAUM MARTIN | Director | Feb 05, 2014 | Buy | $11.00 | 225,818 | 2,483,998 | 2,668,057 | Feb 05, 2014, 05:17 PM |
| RHO Ventures VI LP | 10% Owner | Feb 05, 2014 | Buy | $11.00 | 225,818 | 2,483,998 | 2,668,057 | Feb 05, 2014, 05:14 PM |
| ALTA BIOPHARMA PARTNERS III LP | 10% Owner | Feb 05, 2014 | Buy | $11.00 | 112,817 | 1,240,987 | 1,753,447 | Feb 05, 2014, 04:54 PM |
Load More Insider Transactions
Buy
Sale
Option Exercise
| Owner | Relationship | Date | Value($) |
| Goncalves Joana | CHIEF MEDICAL OFFICER | 04/05/2024 | 2,285 |
| Terrillion Scott | SEC'Y; CHIEF COMPLIANCE & G.C. | 04/05/2024 | 2,285 |
| Terrillion Scott | SEC'Y; CHIEF COMPLIANCE & G.C. | 02/29/2024 | 2,931 |
| Posner Christopher | PRESIDENT AND CEO | 02/29/2024 | 5,192 |
| Goncalves Joana | CHIEF MEDICAL OFFICER | 02/29/2024 | 2,931 |
| Terrillion Scott | SEC'Y; CHIEF COMPLIANCE & G.C. | 02/08/2023 | 4,118 |
| Maynard Ryan D | CHIEF FINANCIAL OFFICER | 02/08/2023 | 2,909 |
| Goncalves Joana | CHIEF MEDICAL OFFICER | 02/08/2023 | 4,118 |
| Posner Christopher | PRESIDENT AND CEO | 02/08/2024 | 18,855 |
| Posner Christopher | PRESIDENT AND CEO | 02/01/2024 | 2,740 |
| Posner Christopher | President and CEO | 11/02/2023 | 4,631 |
| Posner Christopher | President and CEO | 08/03/2023 | 13,222 |
| Terrillion Scott | Sec'y; Chief Compliance & G.C. | 06/23/2023 | 8,715 |
| Menzaghi Frederique Ph.D. | Chief Scientific Off,SVP-R&D | 06/23/2023 | 10,505 |
| Goncalves Joana | Chief Medical Officer | 06/23/2023 | 9,558 |
| Posner Christopher | President and CEO | 05/05/2023 | 17,024 |
| Terrillion Scott | Sec'y; Chief Compliance & G.C. | 04/04/2023 | 12,182 |
| Goncalves Joana | Chief Medical Officer | 04/04/2023 | 12,182 |
| Menzaghi Frederique Ph.D. | Chief Scientific Off,SVP-R&D | 04/04/2023 | 13,419 |
| Posner Christopher | President and CEO | 03/03/2023 | 58,134 |
| Menzaghi Frederique Ph.D. | Chief Scientific Off,SVP-R&D | 03/03/2023 | 66,047 |
| Terrillion Scott | Sec'y; Chief Compliance & G.C. | 03/03/2023 | 60,746 |
| Goncalves Joana | Chief Medical Officer | 03/03/2023 | 60,406 |
| Goncalves Joana | Chief Medical Officer | 02/16/2023 | 23,103 |
| Posner Christopher | President and CEO | 02/02/2023 | 49,454 |
| Goncalves Joana | Chief Medical Officer | 01/17/2023 | 24,485 |
| Goncalves Joana | Chief Medical Officer | 12/29/2022 | 23,058 |
| Menzaghi Frederique Ph.D. | Chief Scientific Off,SVP-R&D | 12/21/2022 | 39,513 |
| Goncalves Joana | Chief Medical Officer | 12/21/2022 | 33,720 |
| Terrillion Scott | Sec'y; Chief Compliance & G.C. | 12/21/2022 | 28,862 |
| Posner Christopher | President and CEO | 11/16/2022 | 161,051 |
| VOGELBAUM MARTIN | Director | 09/14/2022 | 111,024 |
| Ives Jeffrey L. | Director | 07/15/2022 | 32,580 |
| BAINS HARRISON M JR | Director | 07/15/2022 | 65,160 |
| Terrillion Scott | Sec'y; Chief Compliance & G.C. | 04/01/2022 | 19,556 |
| Goncalves Joana | Chief Medical Officer | 04/01/2022 | 19,556 |
| Menzaghi Frederique Ph.D. | Chief Scientific Off,SVP-R&D | 04/01/2022 | 21,247 |
| Posner Christopher | President and CEO | 04/04/2022 | 25,416 |
| Reilly Thomas Charles | Chief Financial Officer | 03/03/2022 | 23,261 |
| Terrillion Scott | Sec'y; Chief Compliance & G.C. | 03/03/2022 | 20,336 |
| Terrillion Scott | Sec'y; Chief Compliance & G.C. | 02/25/2022 | 20,292 |
| Ives Jeffrey L. | Director | 11/12/2021 | 131,207 |
| Goncalves Joana | Chief Medical Officer | 11/01/2021 | 17,150 |
| Goncalves Joana | Chief Medical Officer | 10/27/2021 | 15,000 |
| CHALMERS DEREK T | President & CEO | 09/07/2021 | 309,400 |
| Terrillion Scott | Sec'y; Chief Compliance & G.C. | 08/30/2021 | 24,978 |
| Reilly Thomas Charles | Chief Financial Officer | 08/30/2021 | 28,144 |
| Menzaghi Frederique Ph.D. | Chief Scientific Off,SVP-R&D | 08/30/2021 | 54,627 |
| Goncalves Joana | Chief Medical Officer | 08/30/2021 | 29,962 |
| CHALMERS DEREK T | President & CEO | 08/30/2021 | 119,848 |
| VOGELBAUM MARTIN | Director | 06/07/2021 | 112,752 |
| Posner Christopher | Director | 06/07/2021 | 30,044 |
| Ives Jeffrey L. | Director | 06/07/2021 | 32,886 |
| Goncalves Joana | Chief Medical Officer | 04/21/2021 | 82,890 |
| Goncalves Joana | Chief Medical Officer | 03/22/2021 | 58,950 |
| Menzaghi Frederique Ph.D. | Chief Scientific Off,SVP-R&D | 03/05/2021 | 60,377 |
| Terrillion Scott | Sec'y; Chief Compliance & G.C. | 03/05/2021 | 55,558 |
| Goncalves Joana | Chief Medical Officer | 03/05/2021 | 55,612 |
| CHALMERS DEREK T | President & CEO | 03/05/2021 | 55,792 |
| Terrillion Scott | Sec'y; Chief Compliance & G.C. | 02/25/2021 | 77,397 |
| Menzaghi Frederique Ph.D. | Chief Scientific Off,SVP-R&D | 02/25/2021 | 96,708 |
| Goncalves Joana | Chief Medical Officer | 02/25/2021 | 65,181 |
| CHALMERS DEREK T | President & CEO | 02/25/2021 | 226,722 |
| Goncalves Joana | Chief Medical Officer | 02/22/2021 | 39,460 |
| Goncalves Joana | Chief Medical Officer | 01/21/2021 | 40,240 |
| Terrillion Scott | Sec'y; Chief Compliance & G.C. | 12/30/2020 | 29,774 |
| Menzaghi Frederique Ph.D. | Chief Scientific Off,SVP-R&D | 12/30/2020 | 43,024 |
| Goncalves Joana | Chief Medical Officer | 12/30/2020 | 19,859 |
| CHALMERS DEREK T | President & CEO | 12/30/2020 | 92,993 |
| CHALMERS DEREK T | President & CEO | 12/28/2020 | 80,000 |
| Goncalves Joana | Chief Medical Officer | 12/21/2020 | 30,000 |
| CHALMERS DEREK T | President & CEO | 12/16/2020 | 74,750 |
| CHALMERS DEREK T | President & CEO | 12/10/2020 | 114,675 |
| Goncalves Joana | Chief Medical Officer | 11/23/2020 | 30,620 |
| Ives Jeffrey L. | Director | 11/19/2020 | 39,372 |
| Posner Christopher | Director | 11/19/2020 | 31,638 |
| Ives Jeffrey L. | Director | 11/19/2020 | 39,372 |
| VOGELBAUM MARTIN | Director | 11/17/2020 | 96,540 |
| CHALMERS DEREK T | President & CEO | 11/17/2020 | 188,784 |
| Goncalves Joana | Chief Medical Officer | 11/10/2020 | 30,000 |
| Goncalves Joana | Chief Medical Officer | 10/20/2020 | 30,000 |
| CHALMERS DEREK T | President & CEO | 09/03/2020 | 51,216 |
| CHALMERS DEREK T | President & CEO | 08/03/2020 | 82,100 |
| CHALMERS DEREK T | President & CEO | 07/01/2020 | 85,550 |
| Goncalves Joana | Chief Medical Officer | 06/12/2020 | 161,530 |
| CHALMERS DEREK T | President & CEO | 06/03/2020 | 68,843 |
| CHALMERS DEREK T | President & CEO | 06/01/2020 | 11,200 |
| Ives Jeffrey L. | Director | 06/01/2020 | 9,940 |
| Ives Jeffrey L. | Director | 06/01/2020 | 16,000 |
| CHALMERS DEREK T | President & CEO | 05/20/2020 | 19,200 |
| CHALMERS DEREK T | President & CEO | 05/22/2020 | 5,936 |
| CHALMERS DEREK T | President & CEO | 05/21/2020 | 56,000 |
| CHALMERS DEREK T | President & CEO | 05/12/2020 | 78,864 |
| Ives Jeffrey L. | Director | 05/12/2020 | 24,850 |
| Ives Jeffrey L. | Director | 05/12/2020 | 40,000 |
| Ives Jeffrey L. | Director | 04/21/2020 | 24,850 |
| Ives Jeffrey L. | Director | 04/21/2020 | 40,000 |
| Terrillion Scott | Sec'y; Chief Compliance & G.C. | 04/21/2020 | 42,339 |
| Menzaghi Frederique Ph.D. | Chief Scientific Off,SVP-R&D | 04/21/2020 | 200,889 |
| CHALMERS DEREK T | President & CEO | 04/21/2020 | 98,775 |
| Ives Jeffrey L. | Director | 03/04/2020 | 24,850 |
| Ives Jeffrey L. | Director | 03/04/2020 | 40,000 |
| Ives Jeffrey L. | Director | 02/03/2020 | 24,850 |
| Ives Jeffrey L. | Director | 02/03/2020 | 40,575 |
| Ives Jeffrey L. | Director | 01/02/2020 | 24,850 |
| Ives Jeffrey L. | Director | 01/02/2020 | 40,325 |
| CHALMERS DEREK T | President & CEO | 01/02/2020 | 160,500 |
| Terrillion Scott | Sec'y; Chief Compliance & G.C. | 12/04/2019 | 67,859 |
| Mohindru Mani | CFO & Chief Strategy Officer | 12/04/2019 | 81,073 |
| Ives Jeffrey L. | Director | 12/02/2019 | 13,300 |
| Ives Jeffrey L. | Director | 12/02/2019 | 64,575 |
| CHALMERS DEREK T | President & CEO | 12/04/2019 | 182,418 |
| CHALMERS DEREK T | President & CEO | 12/02/2019 | 257,900 |
| Ives Jeffrey L. | Director | 11/01/2019 | 13,300 |
| Ives Jeffrey L. | Director | 11/01/2019 | 51,700 |
| CHALMERS DEREK T | President & CEO | 11/01/2019 | 103,950 |
| Menzaghi Frederique Ph.D. | Chief Scientific Off,SVP-R&D | 10/25/2019 | 79,640 |
| Menzaghi Frederique Ph.D. | Chief Scientific Off,SVP-R&D | 10/18/2019 | 77,320 |
| Menzaghi Frederique Ph.D. | Chief Scientific Off,SVP-R&D | 10/11/2019 | 74,800 |
| Menzaghi Frederique Ph.D. | Chief Scientific Off,SVP-R&D | 10/04/2019 | 76,760 |
| Ives Jeffrey L. | Director | 10/01/2019 | 13,300 |
| Ives Jeffrey L. | Director | 10/01/2019 | 45,525 |
| CHALMERS DEREK T | President & CEO | 10/01/2019 | 182,800 |
| Menzaghi Frederique Ph.D. | Chief Scientific Off,SVP-R&D | 09/03/2019 | 458,400 |
| Ives Jeffrey L. | Director | 09/03/2019 | 13,300 |
| Ives Jeffrey L. | Director | 09/03/2019 | 58,275 |
| CHALMERS DEREK T | President & CEO | 09/03/2019 | 116,300 |
| Menzaghi Frederique Ph.D. | Chief Scientific Off,SVP-R&D | 08/01/2019 | 464,800 |
| Ives Jeffrey L. | Director | 08/01/2019 | 13,300 |
| Ives Jeffrey L. | Director | 08/01/2019 | 58,100 |
| CHALMERS DEREK T | President & CEO | 08/01/2019 | 232,700 |
| Menzaghi Frederique Ph.D. | Chief Scientific Off,SVP-R&D | 07/17/2019 | 247,390 |
| Mohindru Mani | CFO & Chief Strategy Officer | 07/15/2019 | 526,280 |
| Mohindru Mani | CFO & Chief Strategy Officer | 07/15/2019 | 935,775 |
| Ives Jeffrey L. | Director | 07/01/2019 | 13,300 |
| Ives Jeffrey L. | Director | 07/01/2019 | 54,375 |
| Menzaghi Frederique Ph.D. | Chief Scientific Off,SVP-R&D | 07/01/2019 | 438,000 |
| Terrillion Scott | Sec'y; Chief Compliance & G.C. | 05/29/2019 | 49,238 |
| CHALMERS DEREK T | President & CEO | 05/29/2019 | 118,410 |
| Mohindru Mani | CFO & Chief Strategy Officer | 05/29/2019 | 53,389 |
| Menzaghi Frederique Ph.D. | Chief Scientific Off,SVP-R&D | 05/29/2019 | 241,502 |
| Mohindru Mani | CFO & Chief Strategy Officer | 03/13/2019 | 225,536 |
| Mohindru Mani | CFO & Chief Strategy Officer | 03/13/2019 | 306,704 |
| Menzaghi Frederique Ph.D. | Chief Scientific Off,SVP-R&D | 03/13/2019 | 317,073 |
| Menzaghi Frederique Ph.D. | Chief Scientific Off,SVP-R&D | 03/12/2019 | 55,948 |
| CHALMERS DEREK T | President & CEO | 03/01/2019 | 166,856 |
| Menzaghi Frederique Ph.D. | Sr VP-Research & Development | 02/28/2019 | 26,250 |
| Menzaghi Frederique Ph.D. | Sr VP-Research & Development | 02/25/2019 | 38,500 |
| CHALMERS DEREK T | President & CEO | 02/01/2019 | 299,800 |
| CHALMERS DEREK T | President & CEO | 01/02/2019 | 196,950 |
| CHALMERS DEREK T | President & CEO | 01/04/2019 | 75,200 |
| Menzaghi Frederique Ph.D. | Sr VP-Research & Development | 12/28/2018 | 53,879 |
| Terrillion Scott | Sec'y; Chief Compliance & G.C. | 12/28/2018 | 38,781 |
| CHALMERS DEREK T | President & CEO | 12/28/2018 | 198,287 |
| Mohindru Mani | CFO & Chief Strategy Officer | 12/28/2018 | 56,475 |
| Menzaghi Frederique Ph.D. | Sr VP-Research & Development | 12/03/2018 | 55,080 |
| CHALMERS DEREK T | President & CEO | 12/03/2018 | 363,400 |
| Mohindru Mani | CFO & Chief Strategy Officer | 11/15/2018 | 225,551 |
| Mohindru Mani | CFO & Chief Strategy Officer | 11/15/2018 | 296,777 |
| Menzaghi Frederique Ph.D. | Sr VP-Research & Development | 11/01/2018 | 82,000 |
| Menzaghi Frederique Ph.D. | Sr VP-Research & Development | 11/01/2018 | 56,310 |
| Menzaghi Frederique Ph.D. | Sr VP-Research & Development | 08/06/2018 | 22,500 |
| CHALMERS DEREK T | President & CEO | 11/01/2018 | 375,600 |
| Stauffer Joseph William | Chief Medical Officer | 10/17/2018 | 230,347 |
| Mohindru Mani | CFO & Chief Strategy Officer | 10/17/2018 | 225,551 |
| Mohindru Mani | CFO & Chief Strategy Officer | 10/17/2018 | 323,888 |
| Menzaghi Frederique Ph.D. | Sr VP-Research & Development | 10/01/2018 | 71,970 |
| CHALMERS DEREK T | President & CEO | 10/01/2018 | 475,800 |
| CHALMERS DEREK T | President & CEO | 09/04/2018 | 394,200 |
| Menzaghi Frederique Ph.D. | Sr VP-Research & Development | 09/04/2018 | 59,430 |
| Menzaghi Frederique Ph.D. | Sr VP-Research & Development | 08/20/2018 | 56,670 |
| CHALMERS DEREK T | President & CEO | 07/10/2018 | 412,800 |
| Menzaghi Frederique Ph.D. | Sr VP-Research & Development | 07/02/2018 | 57,000 |
| Menzaghi Frederique Ph.D. | Sr VP-Research & Development | 06/01/2018 | 46,470 |
| Menzaghi Frederique Ph.D. | Sr VP-Research & Development | 05/23/2018 | 136,710 |
| CHALMERS DEREK T | President & CEO | 02/16/2018 | 81,000 |
| Menzaghi Frederique Ph.D. | Sr VP-Research & Development | 02/15/2018 | 45,060 |
| Menzaghi Frederique Ph.D. | Sr VP-Research & Development | 01/24/2018 | 225,000 |
| CHALMERS DEREK T | President & CEO | 01/25/2018 | 18,000 |
| CHALMERS DEREK T | President & CEO | 01/24/2018 | 187,500 |
| Menzaghi Frederique Ph.D. | Sr VP-Research & Development | 11/07/2017 | 49,600 |
| CHALMERS DEREK T | President & CEO | 11/03/2017 | 49,600 |
| CHALMERS DEREK T | President & CEO | 11/01/2017 | 202,560 |
| Menzaghi Frederique Ph.D. | VP-Research & Development | 08/04/2017 | 45,000 |
| Schoell Josef | Chief Financial Officer | 07/26/2017 | 9,000 |
| CHALMERS DEREK T | President & CEO | 07/14/2017 | 24,800 |
| CHALMERS DEREK T | President & CEO | 07/14/2017 | 376,250 |
| Menzaghi Frederique Ph.D. | VP-Research & Development | 07/14/2017 | 45,000 |
| Slagel Dean | Director | 06/29/2017 | 6,468,564 |
| RHO Ventures VI LP | 10% Owner | 03/31/2017 | 9,095,700 |
| Menzaghi Frederique Ph.D. | VP-Research & Development | 04/20/2016 | 54,000 |
| VOGELBAUM MARTIN | Director | 03/17/2016 | 1,221,368 |
| VOGELBAUM MARTIN | Director | 03/16/2016 | 727,834 |
| RHO Ventures VI LP | 10% Owner | 03/17/2016 | 1,221,368 |
| RHO Ventures VI LP | 10% Owner | 03/16/2016 | 727,834 |
| Schoell Josef | Chief Financial Officer | 03/16/2016 | 14,740 |
| CHALMERS DEREK T | President & CEO | 03/15/2016 | 24,800 |
| Menzaghi Frederique Ph.D. | VP-Research & Development | 02/03/2016 | 9,000 |
| Menzaghi Frederique Ph.D. | VP-Research & Development | 02/01/2016 | 45,250 |
| Lewis Michael E | Chief Scientific Advisor | 01/26/2016 | 79,374 |
| Slagel Dean | Director | 01/05/2016 | 531,120 |
| Slagel Dean | Director | 12/31/2015 | 217,192 |
| CHALMERS DEREK T | President & CEO | 01/06/2016 | 215,250 |
| Menzaghi Frederique Ph.D. | VP-Research & Development | 01/04/2016 | 100,800 |
| Slagel Dean | Director | 01/05/2016 | 531,120 |
| Slagel Dean | Director | 12/31/2015 | 217,192 |
| Menzaghi Frederique Ph.D. | VP-Research & Development | 12/01/2015 | 97,260 |
| Menzaghi Frederique Ph.D. | VP-Research & Development | 11/02/2015 | 85,560 |
| Menzaghi Frederique Ph.D. | VP-Research & Development | 10/01/2015 | 83,715 |
| Menzaghi Frederique Ph.D. | VP-Research & Development | 09/01/2015 | 130,410 |
| Schoell Josef | Chief Financial Officer | 08/18/2015 | 66,300 |
| Stauffer Joseph William | Chief Medical Officer | 08/04/2015 | 37,200 |
| Menzaghi Frederique Ph.D. | VP-Research & Development | 08/03/2015 | 149,870 |
| Menzaghi Frederique Ph.D. | VP-Research & Development | 07/01/2015 | 85,540 |
| Lewis Michael E | Chief Scientific Advisor | 07/01/2015 | 84,675 |
| Lewis Michael E | Chief Scientific Advisor | 06/01/2015 | 68,989 |
| Slagel Dean | Director | 05/15/2015 | 736,000 |
| Slagel Dean | Director | 05/19/2015 | 322,660 |
| Slagel Dean | Director | 05/18/2015 | 832,768 |
| Lewis Michael E | Chief Scientific Advisor | 05/01/2015 | 77,268 |
| Lewis Michael E | Chief Scientific Advisor | 04/01/2015 | 71,894 |
| Menzaghi Frederique Ph.D. | VP-Research & Development | 03/09/2015 | 5,000 |
| Lewis Michael E | Chief Scientific Advisor | 03/02/2015 | 73,419 |
| Schoell Josef | Chief Financial Officer | 02/17/2015 | 164,400 |
| Lewis Michael E | Chief Scientific Advisor | 02/02/2015 | 76,977 |
| Stauffer Joseph William | Chief Medical Officer | 12/01/2014 | 100,003 |
| Schoell Josef | Chief Financial Officer | 08/14/2014 | 10,000 |
| VOGELBAUM MARTIN | Director | 02/05/2014 | 2,483,998 |
| RHO Ventures VI LP | 10% Owner | 02/05/2014 | 2,483,998 |
| ALTA BIOPHARMA PARTNERS III LP | 10% Owner | 02/05/2014 | 1,240,987 |
Load More Insider Transactions
FUNDS WITH A POSITION IN CARA THERAPEUTICS INC
| Fund | # Shares Owned | % of Portfolio | % Change | Investing Style |
|---|---|---|---|---|
| BLACKROCK INC. | 3,554,258 | 0.00007% | -4.15% | Other |
| FARALLON CAPITAL MANAGEMENT LLC | 1,556,251 | 0.00574% | -6.62% | Event Driven, Value |
| GEODE CAPITAL MANAGEMENT, LLC | 1,008,959 | 0.00008% | 3.71% | Other |
| AQR CAPITAL MANAGEMENT LLC | 828,799 | 0.00116% | 28.12% | Other |
| RENAISSANCE TECHNOLOGIES LLC | 697,030 | 0.0008% | 123.48% | Other |
| D. E. SHAW & CO., INC. | 146,854 | 0.0001% | New | Other |
| TUDOR INVESTMENT CORP ET AL | 93,116 | 0.00056% | No change | Event Driven, Other |
CHANGE IN SHARES OUTSTANDING FOR CARA THERAPEUTICS INC
STOCK BUYBACKS FOR CARA THERAPEUTICS INC
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
Load More
Period of Report: 12/31/2023
10-K/10-Q Filings: View
Previous Period
% Change in Shares
Quarter
09/30/2023
0.45%
1Q
06/30/2023
0.89%
2Q
03/31/2023
1.13%
3Q
12/31/2022
1.33%
4Q
09/30/2022
1.41%
5Q
06/30/2022
1.62%
6Q
03/31/2022
1.82%
7Q
12/31/2021
3.22%
8Q
09/30/2021
8.71%
9Q
06/30/2021
8.83%
10Q
03/31/2021
9.14%
11Q
12/31/2020
6.31%
12Q
09/30/2020
16.20%
13Q
06/30/2020
16.41%
14Q
03/31/2020
16.60%
15Q
12/31/2019
16.57%
16Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR CARA THERAPEUTICS INC
LOADING...